Skip to content
Screener

McKesson MCK Q4 2025 Annual earnings

Reported May 8, 2025 · After market close

Revenue$90.8BMiss by $3.5B
EPS$10.12Beat by $0.29
Revenue estimate$94.3B
EPS estimate$9.83

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$109.91B
EPS estimate$10.72

Financials

Q4 2025

Income statement

See full
Revenue$90.8B+18.9%
Gross profit$3.6B+1.5%
Operating income$1.6B+30.8%
Net income$1.3B+59.3%
EPS (diluted)$9.92+65.3%

Balance sheet

See full
Cash & equivalents$6.0B+29.9%
Total debt$8.8B+16.8%
Total equity-$2.1B-5.2%
Total assets$75.1B+11.4%

Cash flow

See full
Operating cash flow$7.7B+86.8%
CapEx$169.0M-10.1%
Free cash flow$7.6B+91.4%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$84.34B+20.2%
Enterprise value$87.21B+19.2%
P/E25.6×+2.2×
P/S0.2×0.0×

Profitability

See full
Gross margin3.7%-0.4pp
Operating margin1.2%0.0pp
Net margin0.9%-0.1pp
FCF margin1.5%—

Returns & leverage

See full
Current ratio0.9×0.0×

Segments

By segment

See full
Medical-Surgical Solutions$2.9B+0.7%

FAQ

When did McKesson report Q4 2025 earnings?
McKesson (MCK) reported Q4 2025 earnings on May 8, 2025 after market close.
What were McKesson's Q4 2025 revenue and EPS?
McKesson reported revenue of $90.8B and eps of $10.12 for Q4 2025.
Did McKesson beat estimates in Q4 2025?
Revenue missed the consensus estimate of $94.3B by $3.5B. EPS beat the consensus estimate of $9.83 by $0.29.
How did McKesson's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.9% from $76.4B a year earlier and eps grew 63.8% from $6.18.
Where can I find McKesson's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000927653-25-000034) and the 10-K periodic report (0000927653-25-000036) directly on SEC EDGAR. The filing index links above go to sec.gov.